Showing 311-320 of 3132 results for "".
Revision Skincare® hosts the third annual 2024 Elite Retreat in Dallas, TX
https://modernaesthetics.com/series/revision-skincare/elite-retreat-2024/33806/Chris Murray, VP of Strategic Partnerships, Revision Skincare; Tiphany Hall, PhD, MBA, Chief Growth Officer, Aesthetic Record; and Alex Sisler, Sr. Director of Strategic Accounts, Revision Skincare, share insights into the Elite Retreat meeting including how to attend, what makes it so unique, and tThe Partnership: Practice Findings & Value Adds
https://modernaesthetics.com/series/revision-skincare/the-partnership-practice-findings-value-adds/33741/This session rounds out the Elite Retreat seminars by sharing top practice analytics connected with value adds to ultimately aid in strategic planning for every practice’s future. AlexSandra Sisler, Sr. Director of Strategic Accounts - Revision Skincare® Scott Kera, Executive Vice President - AEVA DIn Focus: The Future of Aesthetics
https://modernaesthetics.com/topics/practice-development/in-focus-the-future-of-aesthetics/35204/An update on M&As and other practice trends that are shaping the specialtyAesthetic Treatments for Asian Patients
https://modernaesthetics.com/ma-issues-index/2016-sept-oct/aesthetic-treatments-for-asian-patients/34356/The growing Asian population and increasing demand for cosmetic procedures is creating both a need and an opportunity for core cosmetic physicians to develop expertise in treating this demographic.Aesthetic Devices: The State of the Art
https://modernaesthetics.com/ma-issues-index/2014-mar-apr/aesthetic-devices-the-state-of-the-art/34652/With innovations continuing in the realm of device-based procedures, physicians are left with many options for incorporating devices into practice.Octane Aesthetics Tech Forum: Combination Treatment Strategies May Evolve for Patients Using GLP-1 RAs
https://modernaesthetics.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-combination-treatment-strategies-may-evolve-for-patients-using-glp-1-ras/54706/Arash Moradzadeh, MD, founder of AM Facial Plastics, shares his perspective on aesthetic treatments and trends poised to disrupt the market in 2026. He discusses the expanding role of GLP-1 RA medications in aesthetics, including what’s on the horizon for these therapies.Octane Aesthetics Tech Forum: GLP-1 RAs, ‘Fat You Can Take Off the Shelf’ to Be Major Changes in 2026
https://modernaesthetics.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-glp-1-ras-fat-you-can-take-off-the-shelf-to-be-major-changes-in-2026/54708/Jonathan Kaplan, MD, MPH, Founder & CEO of DrWell, sat down with Modern Aesthetics at the 2026 Octane Aesthetics Tech Forum. As a panelist in the “GLPs and the Evolving Impact on Aesthetics” session, Dr. Kaplan explains what he believes will be disrupters to the industry this year, what is on thOctane Aesthetics Tech Forum: 2026 to Be Year of Bioregenerative Therapy
https://modernaesthetics.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-2026-to-be-year-of-bioregenerative-therapy/54703/At the 2026 Octane Aesthetics Tech Forum, Kay Durairaj, MD, founder of Beauty by Dr. Kay, sat down with Modern Aesthetics to discuss how bioregenerative therapies, such as peptides and skin maintenance with collagen stimulators, will take 2026 by storm.Ultrasound-Based Treatments in Practice
https://modernaesthetics.com/topics/energy-based-devices/ultrasound-based-treatments-in-practice/48981/Modern Aesthetics Editorial Board member Jennifer Levine, MD, talks about how she utilizes ultrasound technology and which patients can benefit most from it.ASDS: Dr. Omer Ibrahim on Different Ethnic Groups' Body Concerns
https://modernaesthetics.com/conferences/asds-annual-meeting/asds-dr-omer-ibrahim-on-different-ethnic-groups-body-concerns/33846/Omer Ibrahim, MD, FAAD, discusses a survey on different ethnic groups’ cosmetic preferences that was presented at the 2024 American Society for Dermatologic Surgery Annual Meeting.